Reproducing epidemiologic research and ensuring transparency

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Measures for ensuring that epidemiologic studies are reproducible include making data sets and software available to other researchers so they can verify published findings, conduct alternative analyses of the data, and check for statistical errors or programming errors. Recent developments related to the reproducibility and transparency of epidemiologic studies include the creation of a global platform for sharing data from clinical trials and the anticipated future extension of the global platform to non-clinical trial data. Government agencies and departments such as the US Department of Veterans Affairs Cooperative Studies Program have also enhanced their data repositories and data sharing resources. The Institute of Medicine and the International Committee of Medical Journal Editors released guidance on sharing clinical trial data. The US National Institutes of Health has updated their data-sharing policies. In this issue of the Journal, Shepherd et al. (Am J Epidemiol. 2017;186:387- 392) outline a pragmatic approach for reproducible research with sensitive data for studies for which data cannot be shared because of legal or ethical restrictions. Their proposed quasi-reproducible approach facilitates the dissemination of statistical methods and codes to independent researchers. Both reproducibility and quasi-reproducibility can increase transparency for critical evaluation, further dissemination of study methods, and expedite the exchange of ideas among researchers.

Original languageEnglish (US)
Pages (from-to)393-394
Number of pages2
JournalAmerican journal of epidemiology
Volume186
Issue number4
DOIs
StatePublished - Jan 1 2017

Fingerprint

Information Dissemination
Research Personnel
Epidemiologic Studies
Research
Clinical Trials
Government Agencies
United States Department of Veterans Affairs
Statistical Data Interpretation
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
National Institutes of Health (U.S.)
Software

Keywords

  • clinical trials
  • confidentiality
  • de-identification
  • privacy
  • reproducible research

ASJC Scopus subject areas

  • Epidemiology

Cite this

Reproducing epidemiologic research and ensuring transparency. / Coughlin, Steven Scott.

In: American journal of epidemiology, Vol. 186, No. 4, 01.01.2017, p. 393-394.

Research output: Contribution to journalReview article

@article{318ac45b5cac45a4beeefb2eb6437eaa,
title = "Reproducing epidemiologic research and ensuring transparency",
abstract = "Measures for ensuring that epidemiologic studies are reproducible include making data sets and software available to other researchers so they can verify published findings, conduct alternative analyses of the data, and check for statistical errors or programming errors. Recent developments related to the reproducibility and transparency of epidemiologic studies include the creation of a global platform for sharing data from clinical trials and the anticipated future extension of the global platform to non-clinical trial data. Government agencies and departments such as the US Department of Veterans Affairs Cooperative Studies Program have also enhanced their data repositories and data sharing resources. The Institute of Medicine and the International Committee of Medical Journal Editors released guidance on sharing clinical trial data. The US National Institutes of Health has updated their data-sharing policies. In this issue of the Journal, Shepherd et al. (Am J Epidemiol. 2017;186:387- 392) outline a pragmatic approach for reproducible research with sensitive data for studies for which data cannot be shared because of legal or ethical restrictions. Their proposed quasi-reproducible approach facilitates the dissemination of statistical methods and codes to independent researchers. Both reproducibility and quasi-reproducibility can increase transparency for critical evaluation, further dissemination of study methods, and expedite the exchange of ideas among researchers.",
keywords = "clinical trials, confidentiality, de-identification, privacy, reproducible research",
author = "Coughlin, {Steven Scott}",
year = "2017",
month = "1",
day = "1",
doi = "10.1093/aje/kwx065",
language = "English (US)",
volume = "186",
pages = "393--394",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Reproducing epidemiologic research and ensuring transparency

AU - Coughlin, Steven Scott

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Measures for ensuring that epidemiologic studies are reproducible include making data sets and software available to other researchers so they can verify published findings, conduct alternative analyses of the data, and check for statistical errors or programming errors. Recent developments related to the reproducibility and transparency of epidemiologic studies include the creation of a global platform for sharing data from clinical trials and the anticipated future extension of the global platform to non-clinical trial data. Government agencies and departments such as the US Department of Veterans Affairs Cooperative Studies Program have also enhanced their data repositories and data sharing resources. The Institute of Medicine and the International Committee of Medical Journal Editors released guidance on sharing clinical trial data. The US National Institutes of Health has updated their data-sharing policies. In this issue of the Journal, Shepherd et al. (Am J Epidemiol. 2017;186:387- 392) outline a pragmatic approach for reproducible research with sensitive data for studies for which data cannot be shared because of legal or ethical restrictions. Their proposed quasi-reproducible approach facilitates the dissemination of statistical methods and codes to independent researchers. Both reproducibility and quasi-reproducibility can increase transparency for critical evaluation, further dissemination of study methods, and expedite the exchange of ideas among researchers.

AB - Measures for ensuring that epidemiologic studies are reproducible include making data sets and software available to other researchers so they can verify published findings, conduct alternative analyses of the data, and check for statistical errors or programming errors. Recent developments related to the reproducibility and transparency of epidemiologic studies include the creation of a global platform for sharing data from clinical trials and the anticipated future extension of the global platform to non-clinical trial data. Government agencies and departments such as the US Department of Veterans Affairs Cooperative Studies Program have also enhanced their data repositories and data sharing resources. The Institute of Medicine and the International Committee of Medical Journal Editors released guidance on sharing clinical trial data. The US National Institutes of Health has updated their data-sharing policies. In this issue of the Journal, Shepherd et al. (Am J Epidemiol. 2017;186:387- 392) outline a pragmatic approach for reproducible research with sensitive data for studies for which data cannot be shared because of legal or ethical restrictions. Their proposed quasi-reproducible approach facilitates the dissemination of statistical methods and codes to independent researchers. Both reproducibility and quasi-reproducibility can increase transparency for critical evaluation, further dissemination of study methods, and expedite the exchange of ideas among researchers.

KW - clinical trials

KW - confidentiality

KW - de-identification

KW - privacy

KW - reproducible research

UR - http://www.scopus.com/inward/record.url?scp=85028607872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028607872&partnerID=8YFLogxK

U2 - 10.1093/aje/kwx065

DO - 10.1093/aje/kwx065

M3 - Review article

VL - 186

SP - 393

EP - 394

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 4

ER -